Potential risk of TNF inhibitors on the progression of interstitial lung disease in patients with rheumatoid arthritis

OBJECTIVES: Biological therapy represents important advances in alleviating rheumatoid arthritis (RA), but the effect on interstitial lung disease (ILD) has been controversial. The objective of this study was to assess the risk of such treatment for patients with ILD. DESIGN: Case–control cohorts. S...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakashita, Tamao, Ando, Katsutoshi, Kaneko, Norihiro, Takahashi, Kazuhisa, Motojima, Shinji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Respiratory Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139628/
https://www.ncbi.nlm.nih.gov/pubmed/25125479
http://dx.doi.org/10.1136/bmjopen-2014-005615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139628/
https://www.ncbi.nlm.nih.gov/pubmed/25125479
http://dx.doi.org/10.1136/bmjopen-2014-005615

Ejemplares similares